TJ BioTech v. AgroSource: Biotech Patent Dispute Ends in Confidential Settlement
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | TJ BioTech LLC v. AgroSource Inc. |
| Case Number | 9:25-cv-81008 (S.D. Fla.) |
| Court | U.S. District Court for the Southern District of Florida |
| Duration | Aug 2025 – Feb 2026 182 days |
| Outcome | Confidential Settlement |
| Patents at Issue | |
| Accused Products | ReMedium TI® and Rectify™ |
Case Overview
The Parties
⚖️ Plaintiff
Biotech-focused entity asserting proprietary rights over patented technology relevant to agricultural or biological product formulations.
🛡️ Defendant
Agricultural products company operating in a competitive market segment where proprietary formulations and product differentiation carry significant commercial weight.
The Patent at Issue
This case centered on alleged infringement of U.S. Patent No. US12382956B2, covering technology in the biotech/agricultural science domain. The patent is the central intellectual property asset around which all infringement allegations and counterclaims were structured.
- • US12382956B2 — A U.S. Utility Patent covering technology in the biotech/agricultural science domain.
Developing a biotech product?
Check if your formulation might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
The litigation concluded via **joint stipulation of dismissal with prejudice** pursuant to **Federal Rule of Civil Procedure 41(a)(2)**, reflecting a mutually negotiated resolution. Key terms included dismissal of all claims and counterclaims, dissolution of the preliminary injunction, and court retention of jurisdiction to enforce the confidential settlement agreement. No damages figure has been publicly disclosed.
Key Legal Issues
The issuance of a preliminary injunction (Docket Entry 65) mid-litigation is a critical data point. Courts apply a four-factor test for preliminary injunctions: likelihood of success on the merits, irreparable harm, balance of hardships, and public interest. TJ BioTech’s success in securing this relief indicated early judicial receptiveness to its infringement claims — a powerful negotiating lever heading into settlement discussions.
Filing a biotech patent?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in agricultural biotech. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation. The case centered on US12382956B2, a biotech utility patent.
- View related biotech patents in this technology space
- See which companies are active in agri-biotech innovation
- Understand claim construction patterns for biotech patents
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Formulation-based biotech patents
US12382956B2
Central to infringement claims
FTO & Design-Around
Options available with analysis
✅ Key Takeaways
For Patent Attorneys & Litigators
Preliminary injunctions in biotech patent cases can decisively shift settlement dynamics — assess eligibility early.
Search related case law →Rule 41(a)(2) dismissals with prejudice plus court-retained jurisdiction create enforceable, flexible settlement structures.
Explore precedents →Counterclaim strategy matters — all counterclaims were dismissed with prejudice, warranting careful pre-suit analysis.
Analyze litigation strategy →For R&D Leaders
ReMedium TI® and Rectify™ products triggered infringement claims; pre-launch FTO analysis must address formulation-level patent claims.
Start FTO analysis for my product →Biological agricultural input products operate in a dense patent landscape requiring ongoing IP surveillance.
Explore patent landscape →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.